期刊文献+

Study on Plasma Concentration and Bioavailability of Wogonin in Beagle's Dogs

Study on Plasma Concentration and Bioavailability of Wogonin in Beagle's Dogs
原文传递
导出
摘要 Objective To develop an LC-MS/MS method for determining the concentration of wogonin in dog plasma and investigate the pharmacokinetics and bioavailability by different administrations of wogonin in Beagle’s dogs.Methods LC-MS/MS was employed in determining the concentration of wogonin with the selected ion monitoring model after liquid-liquid extraction with ethyl acetate of dog plasma samples.The lower limit of quantification was 0.105 μg/L.Target ions were at m/z 285.0→270.0 for wogonin and 373.3→305.3 for finasteride.In a randomized,self-control,and cross-over study,six male Beagle’s dogs were treated with different administration methods in three test periods.Pharmacokinetic parameters were calculated with DAS software(Ver.2.0).Results The calibration curve was linear in the range of 0.105-107.36 μg/L for wogonin in dog plasma samples.The main pharmacokinetic parameters of ig administration(native drug of 15 mg/kg and solution preparation of 5 mg/kg) and iv route were as follows:Cmax(2.5 ± 1.1),(7.9 ± 3.3),and(6838.7 ± 1322.1) μg/L,tmax(0.7 ± 0.3) and(0.3 ± 0.2) h for the both former,AUC0-t(7.1 ± 2.0),(21.0 ± 3.2),and(629.7 ± 111.8) μg.h/L.The absolute bioavailability of native and solution of wogonin were(0.59 ± 0.35)% and(3.65 ± 2.00)%,respectively.Conclusion The validated method is convenient,sensitive,and specific,and the improvement of wogonin solubility could remarkably increase the absolute bioavailability. Objective To develop an LC-MS/MS method for determining the concentration of wogonin in dog plasma and investigate the pharmacokinetics and bioavailability by different administrations of wogonin in Beagle's dogs.Methods LC-MS/MS was employed in determining the concentration of wogonin with the selected ion monitoring model after liquid-liquid extraction with ethyl acetate of dog plasma samples.The lower limit of quantification was 0.105 μg/L.Target ions were at m/z 285.0→270.0 for wogonin and 373.3→305.3 for finasteride.In a randomized,self-control,and cross-over study,six male Beagle's dogs were treated with different administration methods in three test periods.Pharmacokinetic parameters were calculated with DAS software(Ver.2.0).Results The calibration curve was linear in the range of 0.105-107.36 μg/L for wogonin in dog plasma samples.The main pharmacokinetic parameters of ig administration(native drug of 15 mg/kg and solution preparation of 5 mg/kg) and iv route were as follows:Cmax(2.5 ± 1.1),(7.9 ± 3.3),and(6838.7 ± 1322.1) μg/L,tmax(0.7 ± 0.3) and(0.3 ± 0.2) h for the both former,AUC0-t(7.1 ± 2.0),(21.0 ± 3.2),and(629.7 ± 111.8) μg.h/L.The absolute bioavailability of native and solution of wogonin were(0.59 ± 0.35)% and(3.65 ± 2.00)%,respectively.Conclusion The validated method is convenient,sensitive,and specific,and the improvement of wogonin solubility could remarkably increase the absolute bioavailability.
出处 《Chinese Herbal Medicines》 CAS 2011年第2期144-149,共6页 中草药(英文版)
基金 the Colleges and Universities Natural Science Foundation of Anhui Province (KJ2009B216Z)
关键词 Beagle's dogs BIOAVAILABILITY LC-MS/MS PHARMACOKINETICS SOLUBILITY WOGONIN Beagle's dogs bioavailability LC-MS/MS pharmacokinetics solubility wogonin
  • 相关文献

参考文献10

  • 1Chen XY;Wang HY;Du Y;Zhong DF.Quantitation of the flavonoid wogonin and its major metabolite wogonin-7β-D-glucuronide in rat plasma by liquid chromatography tandem mass spectrometry,2002(02).
  • 2杜玥,陈笑艳,杨汉煜,钟大放.液相色谱串联质谱法测定大鼠血浆中的汉黄芩素[J].药学学报,2002,37(5):362-366. 被引量:27
  • 3Guo Q;Zhao L;You Q;Yang Y Gu H Song G Lu N Xin J.Anti-hepatitis B virus activity of wogonin in vitro and in vivo[J],2007(01).
  • 4Hui KM;Huen MS;Wang HY;Zheng H Sigel E Baur R Ren H Li ZW Wong JT Xue H.Anxiolytic effect of wogonin,a benzodiazepine receptor ligand isolated from Scutellaria baicalensis Georgi[J],2002(09).
  • 5Kim YH;Jeong DW;Paek IB;Ji HY Kim YC Sohn DH Lee HS.Liquid chromatography with tandem mass spectrometry for the simultaneous determination of baicalein,baicalin,oroxylin A and wogonin in rat plasma,2006(02).
  • 6Lee DH;Kim C;Zhang L;Lee YJ.Role of p53,PUMA,and Bax in wogonin-induced apoptosis in human cancer cells[J],2008(10).
  • 7Lu N;Gao Y;Ling Y;Chen Y Yang Y Gu HY Qi Q Liu W Wang XT You QD Guo QL.Wogonin suppresses tumor growth in vivo and VEGF-induced angiogenesis through inhibiting tyrosine phosphorylation of VEGFR2,2008(17-18).
  • 8Park HG;Yoon SY;Choi JY;Lee GS Choi JH Shin CY Son KH Lee YS Kim WK Ryu JH Ko KH Cheong JH.Anticonvulsant effect of wogonin isolated from Scutellaria baicalensis,2007(2-3).
  • 9Tsai TH;Chou CJ;Tsai TR;Chen CF.Determination of wogonin in rat plasma by HPLC and its pharmacokinetics application[J],1996(03).
  • 10Zhang HW;Yang Y;Zhang K;Qiang L Yang L Yang L Hu Y Wang XT You QD Guo QL.Wogonin induced differentiation and G1 phase arrest of human U-937 leukemia cells via PKC5 phosphorylation,2008(1-3).

二级参考文献3

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部